AUSTIN, Texas, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. MTEM, a clinical-stage oncology company focused on the discovery and development of the company's proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer, today announced that its management will provide a corporate update at the forthcoming Ladenburg Thalmann 2018 Healthcare Conference and Cantor Global Healthcare Conference, both in New York City.
Ladenburg Thalmann Presentation Details
Date: Tuesday, October 2
Time: 9:30am Eastern Time
Location: Sofitel New York Hotel
Webcast: http://wsw.com/webcast/ladenburg4/mtem/
Cantor Presentation Details
Date: Wednesday, October 3
Time: 1:05pm Eastern Time
Location: InterContinental New York Barclay Hotel
About Molecular Templates
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates' website at www.mtem.com.
Investor Contact:
Adam Cutler
Chief Financial Officer
adam.cutler@mtem.com
862-204-4006
Source: Molecular Templates, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
